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The Hawaii Society ol (hnical Oncology HSC() ) is a not for pro! it
organitanon founded in 1996. in order to ads aticc the quality ol
oncology care across the State ol Hass an. The IISCO is intended to
provide a forutn for all physicians interested in oncology to share
their coni non c mcerns. and to act as a vehicle I or discussion’.
(iItcoloy practices. conti ciii ing ed itc at ion, and access to quah
Ik’o k igs c ate
What initiall\ began as a small group of concerned oncoloe\
specialists, meeting bright early on Saturday mornings, the
HSCO has blossomed and flourished, I am proud to serve as the new
president of HSCO.
As the first President of the HSCO, Dr. Carl Higuchi was insiru
mental in providing the foundation, the insight, and the directioit to
this society. The HSCO was ushered into the iieo mtlleniutn under
the arispices of Dr. I,aeioit Ring. whose tireless atid etiergetic
demeanor was able to foster the oro’ th of this society. His hard
work. dedicat rt in. and devotion provided strong leadership to t Ite
I ISCO.
C’urrentl the Hawaii Societ ol Clinical Oncology is comprised
of a membership of 76 health care professionals, including 45
physicians. This diversified membership. including those from
neighbor islands, incorporates medical doctors, registered nurses.
oncology nurse.inasters of public health, pharmacists. researc hers.
research ssorkers. and geneticists in the Hass att Societc of Clinical
Oncoloev.
I ISC() strives to be identi fled as the voice ol Ilass au’’. oncologist’.
o promote qual i t’ oncoloev care t hrortgh pat i cit t advocac . tort —
tinuing medical education, nuultidisciplinar engagement, and par—
net pation in the public forum
The goals of the HSCO are to advance quality oncology care
across Hawaii, provide a forum for all physicians interested in
oncology to share their common concerns, and to act as a vehicle for
discussions on oncology practice. continuing education, and tetni
hursement issue’.,
iThe l—ISCO h ipes to ronloic erassroot’. ads icac\ [rograins.
identity futute leaders ot this societc. and ptos ide a forum br
discussion on clinical trial lcv’i’.Iation. The 1-ISCO hopes to respond
to tlte he islatis e and the reeLilatr\ concertis of die membership. to
enhance cont in iii ng medical ed uc at rn for membership. and
enhance communication within the memhership
The HSC() is coordinated through its affiliation with the Associa
tion of the Community Cancer Centers (ACCC). In addition, this
society is affiliated with national organizations including the Amen—
can Society of Clinical Oncoloc\ ASCO, and the Council ol
Associated Reciotial Radiation t)ncdog Societte’. CARROS
H it it nit in ilk ‘ji) stilt ih I 1Sf I I i J stI th iii
Governor’s Blue Ribbon Panel on Cancer Care in Hawaii as well as
with the Hawaii Medical Association,
One of the niator puiposes of the HSCO is to help guide our state
senators a id members of Con gi’ess. ni utidersiandi ng the concerns
of the oncolog coin mutinies within the State of Hawaii. We have
been in conlinunication si ith Senators Akaka and Itiort e as well as
Cotivressss oman Mink and C’oneressman Abercromhie. The HSCO
is opposed to the healthcare tinanctito adntintstration HCFA
regai’ding possible cuts in reimbursement for cancer therapies ap
plying pasinent caps to cancer drugs. The society is deeply con
cerned that cancer patients in the State of Hawaii have access to
Medicare payments for certain drugs including all new oral antican—
certherapie.Additional legislative issues that the 1-ISCO is s orking
on are the ambulatory pa ment classifications APC and a erage
ss hole sale price AWPt ot cheniotherap\ agents. The I ISCO is
deeply ci mcerned that teduct ion and i’et inburse ment for chic i ito—
therap acqu ition vs it hiout accompany i nit i m’reases in chic tm—
therap adniutistration threatens patient’s access to ness er agents in
quahit\ of care. In this regard. the HSCO, ni association ss dli ACCC,
is working to educate Congress on this issue. The Hawaii Society of
Clinical Oncology is also actively involved in the Medicare carrier
advisory committees, as well as providing input to the proposed
revisions to regulations to medical privac\
Benefits of belonging to the IISCO:
* Impros ed coininutiit cancer care b implementing present
knowledge and technolog i’elated to cancer detection, diagnosis.
treat nient and rehahi Ii tat ion so that it is made available to t lie
greatest number 0! cancer patients possible:
• Representation at Medicare carrier ads msory committee meetings:
• Up-to-date communications with menibers on issues affecting
patients’ access to cancer care and the practice of oncology:
* Scientilte and economic educational rrteetings:
• Leadership and networking opportunities:
• Qtiarterl state oncolog socmet\ ness sletter:
* ACCC binionthl’\ italics I or oncolog\ m’.sues:
* Compendia—based drug btilletiti:
• Atiswers to codni and renuhurseinent questions via the reiin
bursement hothine and state societ website:
• Representation at ACCC president’s retreat:
• Representation at ACCC radiation oncology policy institute:
• Representation afASCO’s clinical practice committee meetings,
The HSCO works in partnership with the Cancer Research Center
oI’Hass au CRCH to assitre that its members are kept abreast of the
latest cancer research I tidings on a national and local level a’. well
as to pros ide valuable educational opportuititiesA a HSCO
part ncr. a al of the Cancer Rest’ arch Ce titei’ i’. to ci niduct transl a—
tiotial research that tiansUrs the results ot laboratory research to the
chnical t’c’.eaich setting with the espectation of unpros ing the
quality of tancer care delis cred to the patients of Hawaii. Through
its Chitiical Sciences Program, the Cancer Center conducts approxi
mately 150 clinical trials which are available to all eligible cancer
pa.tie.nts.
As prc—idcnt of the FISCO. I would like to help the ‘.ociety
encoutace it’. metnhership ii enroll their patient’. in the multitude of
clinical titals available throuch the CRt.’H and other stateSk tde
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institutions. I ctirrenth also serve 4s the Han an State Chairman for
the American Colles’e of Surgeons Cancer Liaison prouram br the
Commission on Cancer. I n ill continue io provide the hospitals and
the State of Han au. the HSCO. and the (‘RCH with new research
protocols as ai I able through the A inerican College of Surgei in On
cology Group. I also plan to share with the society, new legislatise
efforts for the American College of Surgeons as well access to the
National Cancer database n hich can compare the results of site
specific cancer care therapy in the State of Hawaii with the national
benchmark standards of the mainland,
This year the 1-ISCO, in conjunction ss ith the American Cancer
Society and other staten ide organizations. plans to support legisla
tion to make the State Capital a smoke tree building. We also support
legislation to make tobacco sales to minors a mandator offense
with a line. \\e will continue to support the Lit I Ii ration of t baeco
settlement dollars goin to the Hawaii Tobacco Prevention and
Control Trust Fund,
In closing, as you can see there is a distinctive collaborative
pattern between the practitioners of oncology care, the HSCO and
the CRCH. Together, we plan to advance quality of oncology care
for the patients in the State of Hawaii,
For your information
The Hass au Societ of Clinical Oncology annual nieeling will he
held on November 23. 20(12 at the Shriner’s Hospital fl.r Children.
Dr. Joseph Bailes. Chief Public Polic Liaison for the American
Societ\ of Clinical Oucologv, will omn us again as a guest speaker
In addition, Mr. Rick Newton, Certified Public Accountant will
pros ide a presentation to update the membership on the topic of
“Cost accounting for the oncology practice”. For more information
visit the HSCO website: hsco/hawaii.eom, Visit www .crchoru for
more information about the Cancer Research Center of Hawaii,
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